By SMi Group
SMi Group’s 13th Annual Conference:
RNA Therapeutics 2022
9th – 10th February 2022
Sponsored by: BIA Separations & eTheRNA Immunotherapies
Bolstering the latest advances and opportunities in RNA-based medicine
The RNA therapeutics industry has grown at an exponential rate in recent years, with an increased spotlight following the industry’s leading role in developing vaccines against COVID-19 in response to the global pandemic. This year’s conference will reflect on how the industry has adapted and played a pivotal role in global health over the past year and will discuss the takeaways for future mRNA therapeutic development.
The 2022 agenda will explore innovations in novel and targeted delivery, RNAi innovations and antisense oligonucleotide therapeutics. Global experts from big pharma and leading biotechs will explore the emerging therapeutic applications of RNA with case studies on the treatment of cardiovascular disease, neurological diseases, and oncology.
Join us in February 2022, as SMi’s 13th annual RNA Therapeutics Conference brings together industry experts from leading RNA therapeutics companies to gain an expert and holistic view on the latest developments of the industry.
BENEFITS OF ATTENDING:
View the full agenda and speaker line-up online:
Chair for 2022:
Heinrich Haas, VP RNA Formulation and Drug Delivery, BioNTech
Focus Day Chair for 2021:
Steve Pascolo, Founder and CEO, Miescher Pharma
Who should attend:
EARLY BIRD OFFERS:
Register by 30th November 2021 to save £200
Register by 17th December 2021 to save £100
Registrations can be made on the event website at: www.therapeutics-rna.com/fatsoma
Additional Contact Info:
T: +44 (0) 20 7827 6154
Follow us: @SMiPharm – Twitter | SMiPharma – LinkedIn